NMD Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of NMD Antibodies for studying nonsense-mediated mRNA decay (NMD) pathways. NMD Antibodies support multiple research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NMD is a critical cellular mechanism that identifies and degrades mRNAs containing premature stop codons, thereby preventing the production of truncated and potentially harmful proteins. The process plays a vital role in maintaining cellular homeostasis and regulating gene expression, making NMD essential for proper cellular function and response to stress. Dysregulation of NMD has been implicated in various diseases, including cancer and genetic disorders, highlighting the significance of understanding this pathway. Research into NMD pathways continues to reveal new insights about cellular quality control mechanisms and their role in disease development. Investigating NMD mechanisms can lead to improved therapeutic strategies for treating genetic disorders and cancers. Santa Cruz Biotechnology monoclonal NMD antibodies enable researchers worldwide to advance scientific knowledge of mRNA surveillance mechanisms and their implications in health and disease.